BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 20977579)

  • 1. Limitations of metformin use in patients with kidney disease: are they warranted?
    Vasisht KP; Chen SC; Peng Y; Bakris GL
    Diabetes Obes Metab; 2010 Dec; 12(12):1079-83. PubMed ID: 20977579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do risk factors for lactic acidosis influence dosing of metformin?
    Millican S; Cottrell N; Green B
    J Clin Pharm Ther; 2004 Oct; 29(5):449-54. PubMed ID: 15482389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Four cases of lactic acidosis following metformin treatment].
    Frid A; Sterner G
    Lakartidningen; 2006 Sep 6-12; 103(36):2560-2. PubMed ID: 17007201
    [No Abstract]   [Full Text] [Related]  

  • 4. Metformin associated lactic acidosis: incidence and clinical correlation with metformin serum concentration measurements.
    van Berlo-van de Laar IR; Vermeij CG; Doorenbos CJ
    J Clin Pharm Ther; 2011 Jun; 36(3):376-82. PubMed ID: 21545617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Proposal for the modification of metformin use in patients with chronic kidney disease].
    Balogh Z; Mátyus J
    Orv Hetil; 2012 Sep; 153(39):1527-35. PubMed ID: 23000419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin-associated lactic acidosis: case reports and literature review.
    Chang CT; Chen YC; Fang JT; Huang CC
    J Nephrol; 2002; 15(4):398-402. PubMed ID: 12243370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse event notifications implicating metformin with lactic acidosis in Australia.
    Huang W; Castelino RL; Peterson GM
    J Diabetes Complications; 2015; 29(8):1261-5. PubMed ID: 26104729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review: metformin: potential benefits and use in chronic kidney disease.
    Pilmore HL
    Nephrology (Carlton); 2010 Jun; 15(4):412-8. PubMed ID: 20609092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Does a reduced kidney function (creatinine clearance 10-15 ml/min), without acidosis, increase the risk for the rise of lactic acidosis caused by metformin?].
    Heine RJ
    Ned Tijdschr Geneeskd; 2002 Nov; 146(46):2213. PubMed ID: 12583406
    [No Abstract]   [Full Text] [Related]  

  • 10. Discrepancies among consensus documents, guidelines, clinical practice and the legal framework for the treatment of type 2 diabetes mellitus patients.
    del Pozo-Fernández C; Pardo-Ruiz C; Sánchez-Botella C; Blanes-Castañer V; López-Menchero R; Gisbert-Sellés C; Sánchez-Jodar C; Alvarez-Avellán L
    Nefrologia; 2012 May; 32(3):367-73. PubMed ID: 22592422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lactate levels in Asian patients with type 2 diabetes mellitus on metformin and its association with dose of metformin and renal function.
    Lim VC; Sum CF; Chan ES; Yeoh LY; Lee YM; Lim SC
    Int J Clin Pract; 2007 Nov; 61(11):1829-33. PubMed ID: 17887995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin use in decompensated heart failure.
    Boyd A; Nawarskas J
    Cardiol Rev; 2008; 16(5):269-72. PubMed ID: 18708828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin therapy in patients with chronic kidney disease.
    Duong JK; Roberts DM; Furlong TJ; Kumar SS; Greenfield JR; Kirkpatrick CM; Graham GG; Williams KM; Day RO
    Diabetes Obes Metab; 2012 Oct; 14(10):963-5. PubMed ID: 22564555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The nephrologist's role in metformin-induced lactic acidosis.
    Gómez-Navarro L; de Arriba G; Sánchez-Heras M; Pérez del Valle KM; Hernández-Sevillano B; Basterrechea MA; Tallón S; Torres-Guinea M; Rodríguez-Palomares JR
    Nefrologia; 2011; 31(5):587-90. PubMed ID: 21959726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin-associated lactic acidosis treated with continuous renal replacement therapy.
    Alivanis P; Giannikouris I; Paliuras C; Arvanitis A; Volanaki M; Zervos A
    Clin Ther; 2006 Mar; 28(3):396-400. PubMed ID: 16750454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fulminant lactic acidosis in two patients with Type 2 diabetes treated with metformin.
    Brassøe R; Elkmann T; Hempel M; Gravholt CH
    Diabet Med; 2005 Oct; 22(10):1451-3. PubMed ID: 16176212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hospitalization for Lactic Acidosis Among Patients With Reduced Kidney Function Treated With Metformin or Sulfonylureas.
    Chu PY; Hackstadt AJ; Chipman J; Griffin MR; Hung AM; Greevy RA; Grijalva CG; Elasy T; Roumie CL
    Diabetes Care; 2020 Jul; 43(7):1462-1470. PubMed ID: 32327421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three cases of severe metformin-related lactic acidosis.
    Carlon R; Dal Cero P; Corbanese U; Possamai C
    Eur J Anaesthesiol; 2010 Jul; 27(7):666-7. PubMed ID: 19949340
    [No Abstract]   [Full Text] [Related]  

  • 19. [Metformin treatment causes persisting lactic acidosis after cardiac arrest].
    Gamst J; Hansen LK; Rasmussen BS
    Ugeskr Laeger; 2010 Dec; 172(49):3418-9. PubMed ID: 21129321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lactate levels and risk of lactic acidosis with metformin in diabetic kidney disease patients.
    Bipi PK; George J; Gomathy S; Gracious N; Kumar S; Mohandas MK
    Saudi J Kidney Dis Transpl; 2017; 28(6):1356-1361. PubMed ID: 29265047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.